The shadowy world of sports supplements

March 16, 2017
00:0000:00

Rob_Tauler.jpg

 

Robert Tauler, managing partner at Tauler Smith, a Los Angeles attorney who protects the nutritional supplement market from people who openly sell illegal steroids and amphetamines as sports supplements joins eHealth Radio and the Health News, Legal & Supplement Channels.

 

Listen to interview with host Eric Michaels & guest Robert Tauler discuss the following:

  • Tell us a bit about problem of illegal steroids being sold right out in the open online and in sports nutrition stores. How big is the problem and what’s at stake?
  • How do these companies work and why can they operate so openly? Where’s the FDA in policing this problem?
  • What are the most common kinds of illegal supplements being sold right now, how do they work, and what are the risks and known side-effects? Do you know of any cases of someone suffering serious physical injury from illegal supplements that you can share with us?
  • How do you use the law to go after these bad actors? How effective have you been in getting the courts to force these people to take these poisons off the market?
  • Who is the market these people sell to? Can you tell us something about the buyers and the sellers? Who makes these supplements? Do the makers of these supplements have any medical backgrounds or qualifications that lets them experiment on customers with unapproved pharmaceutical research drugs?
  • How can unsuspecting people protect themselves from these substances? What should they know? How should they read a supplement’s label?

 

Los Angeles trial attorney Robert Tauler devotes the majority of his practice to nutritional supplement litigation, specifically eliminating steroid and amphetamine analogs from over-the-counter sports supplements. These drugs are sold openly in stores and online under all sorts of names with no warnings about side effects, whether the chemicals have been banned for human consumption, or whether they are outright illegal — as all steroids are without a doctor’s prescription.

In 2016, he was  awarded "Attorney of the Year" by the Los Angeles Westside Bar Association. In 2015 he obtained a $10 million jury verdict against a supplement manufacturer, which was among the top 25 highest verdicts in California that year.

Tauler, a native Californian, is a 2005 graduate from Harvard Law School. He was honored as an NCAA Big West Scholar-Athlete while an undergraduate at the University of California, Irvine, where he majored in political science and played on the Anteater’s nationally-ranked men’s volleyball team.

 

Tauler-Smith-LLP-Logo-300-300x60.png

 

Website: taulersmith.com

Importing Prescription Drugs from Other Countries, Including Canada, Puts U.S. Consumers at Risk

March 9, 2017
00:0000:00

AAEAAQAAAAAAAAV5AAAAJGU0OWYzNmIyLWM5YjItNDBiZC1hMDFkLWNlZDdmNmEwNzUyZQ.jpg

 

Libby Baney, Principal at Faegre Baker Daniels Consulting and Executive Director of the Alliance for Safe Online Pharmacies, a non-profit organization dedicated to making the Internet safe for consumers worldwide again joins eHealth Radio and the Pharmaceutical & Health News Channels. ASOP Global recently launched a campaign to educate policymakers, consumers and others about the dangers of buying prescription drugs from other countries, including Canada.

 

Listen to interview with host Eric Michaels and guest Libby Baney discuss the following:

  • How prevalent are illegal online pharmacies?
  • There’s been a lot of discussion about legalizing the importation of prescription drugs from Canada. What Do U.S. Residents Get When They Search for a “Canadian Online Pharmacy”?
  • Are There ANY Legitimate Canadian Online Pharmacies?
  • Why Can’t Congress Just Make It Legal for U.S. Residents to Buy From Only Websites Supplying from Actual Canadian Pharmacies?
  • Doesn't this new importation bill have built-in safeguards?
  • Can the U.S. Increase U.S. Government Enforcement Authority and Penalties for Illegal Actors?
  • What Are the Risks to U.S. Residents Who Buy From a “Canadian” Online Pharmacy?
  • What can consumers do to stay safe when shopping for medicines online?

 

Libby Baney is the executive director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C. which she founded in 2009. In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers.

A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.

Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.

In addition to her work for ASOP, Libby is a partner at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.

 

Screen_Shot_2016-12-08_at_12_37_32_PM.png

Website: www.BuySafeRx.pharmacy

Facebook: https://www.facebook.com/BuySafeRx

Building a Better Fat Trap. Q & A with Gary Thompson, M Pharmaceuticals

January 21, 2017
00:0000:00

GaryTHead.jpg

Gary Thompson, President and CEO of M Pharmaceuticals USA, a clinical-stage company developing innovative technologies for obesity and weight management joins eHealth Radio and the Health News, Pharmaceutical & Weight Management Channels.

 

Listen to interview with host Eric Michaels and guest Gary Thompson discuss the following:

  • A fat loss drug is the holy grail, what has been the challenges in developing a drug that actually works?
  • With drugs that "trap fat", what have been the issues surrounding Orlistat products currently on the market?
  • Your company has redesigned this drug, now called C-103, to address "bathroom issues", how does this new drug work?
  • What have studies for C-103 demonstrated so far?
  • Would your drug work against other illnesses that affect the obese such as fatty liver disease, if so, how?
  • What is the next step for your diet drug?

 

Gary A. Thompson, B.S. is President & CEO M-Pharmaceutical U.S.A. Inc. Thomspon has 30 years plus of sales and management experience in Fortune 500 health care organizations and start up pharmaceutical companies. He has served as Vice President of sales for Cigna Healthcare managing billions of assets over his career. Mr. Thompson's management and leadership roles with start up ventures including ToConceive LLC., (510K FDA Clearance ) in women's health and wellness, and in the obesity space as President of M-Pharma's newly acquired Chelatexx, LLC., C-103 reformulated orlistat.

 

Screen_Shot_2017-01-21_at_1_50_25_PM.png

Website: www.m-pharma.ca

Social Media Links:
Facebook: facebook.com/pages/M-Pharmaceutical-Inc
Twitter: @MPharmaceutical

Healthcare Providers Have a Vital Role to Play in Educating Patients About Illegal Online Pharmacies

December 8, 2016
00:0000:00

asop_staff_libby.jpg

Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies, a non-profit organization dedicated to making the Internet safe for consumers worldwide again joins eHealth Radio and the Pharmaceutical & Health News Channels.

ASOP Global recently launched a campaign to educate pharmacists, doctors and other healthcare providers about illegal online pharmacies, counterfeit medicines and the tools they need to help keep their patients safe online.

Listen to interview with host Eric Michaels and guest Libby Baney discuss the following:

  • What is the Alliance for Safe Online Pharmacies?
  • Why is the focus of your new campaign healthcare providers?
  • How prevalent are illegal online pharmacies?
  • What are the risks associated with buying prescription drugs from illegal online pharmacies?
  • Can you tell our listeners what to look out for to avoid these dangers?

Summary: What can consumers do to stay safe when shopping for medicines online? Consumers should visit www.BuySafeRx.pharmacy to verify whether a website is safe BEFORE they order any prescription medicines online. We also encourage consumers to look for websites that end in dot-pharmacy, like www.medlife.pharmacy and www.safe.pharmacy, because only entities that are approved by NABP legally qualify to have a dot-pharmacy website. 

Libby Baney is the executive director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C. which she founded in 2009. In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers.

A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.

Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.

In addition to her work for ASOP, Libby is a partner at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.

Screen_Shot_2016-12-08_at_12_37_32_PM.png

Website: www.BuySafeRx.pharmacy

Social Media Links:
Facebook: facebook.com/BuySafeRx
Twitter: @BuySafeRx

Certified Geriatric Pharmacist Credential Moving to the Board of Pharmacy Specialties

November 14, 2016
00:0000:00

Bill_Ellis_Headshot.jpg

William Ellis, Executive Director of the Board of Pharmacy Specialties® in Washington, D.C. joins eHealth Radio and the Health Care and Health News Channels. BPS, which is celebrating its 40th anniversary this year, is the premier post-licensure certification organization serving the pharmacy profession.

Listen to interview with host Eric Michaels and guest William Ellis discuss the following:

  • What is the Board of Pharmacy Specialties?
  • How many pharmacists are currently BPS board certified?
  • What sets BPS board certified pharmacists apart from other pharmacists?
  • What role does the BPS board certified pharmacist play as an integral member of the healthcare team?
  • BPS recently announced that pharmacists board certified by the Commission for Certification in Geriatric Pharmacy will now be BPS Board Certified Geriatric Pharmacists. Can you tell us about the implications of this news?

Duration: 8:52

William M. Ellis is the Executive Director for the Board of Pharmacy Specialties® (BPS), an autonomous division of the American Pharmacists Association (APhA), in Washington, D.C.  From 1997-2011, he served as CEO and Executive Director of the American Pharmacists Association (APhA) Foundation.  Ellis was the Executive Vice President for the Pennsylvania Society of Health-Systems Pharmacists from 1986-1997.
 
Ellis also serves as Chair of the Council on Credentialing in Pharmacy which provides leadership, guidance, public information, and coordination for the profession of pharmacy's credentialing programs. In 2014, he was appointed a commissioner to the National Commission for Certifying Agencies.
 
After receiving his pharmacy degree from the Philadelphia College of Pharmacy (PCP), Ellis completed an executive residency with the American Society of Health-System Pharmacists in 1986 and earned his Master of Science degree in health education from Saint Joseph’s University in Philadelphia in 1994. Currently he also is serving as the chair of the Philadelphia College of Pharmacy’s Board of Visitors.

Website: www.bpsweb.org

Social Media Links:
Facebook: https://www.facebook.com/BoardofPharmacySpecialties
Twitter: @BPSweb

Medication errors: The deadly problem no one is talking about

July 6, 2016
00:0000:00


Dr. Raj Gopalan, MD, MSIS, Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI) joins eHealth Radio and Health Care and Pharmaceutical Channels to discuss medication errors, the deadly problem no one is talking about.


Listen to interview with host Eric Michaels & guest Dr. Raj Gopalan discuss the following:

  • he BMJ recently reported that medical errors have become the third leading cause of death in the U.S., and other reports note that the U.S. experiences some 124,000 deaths a year specifically due to medication errors. In your experience trying to improve medication safety, what are some examples of the types of medication errors you’ve encountered?
  • What has changed over the years to make this more of a pressing issue?
  • How can clinicians reduce these errors and what kind of solutions are currently available to help them?
  • What are the next steps for the healthcare community? What developments need to be made to further and more effectively pursue the reduction of medication errors?
  • You mentioned that Wolters Kluwer Clinical Drug Information is working on advancements to help address the issue of medication errors. What are some of those advancements, and how will they play a role in helping reduce medication errors?


Duration: 13:15


Raj Gopalan, MD, MSIS, is the Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI), focused on developing next-generation of health information technology and clinical decision support innovations to help enable healthcare organizations to deliver precision care to patients with utmost efficiency.


Prior to joining Wolters Kluwer, Dr. Gopalan has served as a Clinical Architect and Medical Director of a large academic medical center, and as a CMIO of a large multihospital integrated delivery networks. He has also worked as a Clinical Architect for technology companies. In previous roles, he has designed, developed and implemented EMR systems across multiple community and urban hospitals.



Website: www.wolterskluwercdi.com


Follow Wolters Kluwer Clinical Drug Information:
Facebook: facebook.com/WoltersKluwerClinicalDrugInformation
Twitter: @WKDrugInfo
LinkedIn: linkedin.com/company/wolters-kluwer-clinical-drug-information

Keeping Seniors Safe from Illegal Online Pharmacies and Counterfeit Medicines

June 13, 2016
00:0000:00


Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies, an international non-profit organization dedicated to protecting the safety of consumers online again joins eHealth Radio and the Pharmaceutical & Health News Channels.


Listen to interview with host Eric Michaels & guest Libby Baney discuss the following:

  • What is the Alliance for Safe Online Pharmacies? 
  • Why is the focus of your new campaign seniors and their caregivers?
  • Can you give us some examples of what kinds of costs seniors are looking at?
  • How prevalent are illegal online pharmacies?
  • What are the risks associated with buying prescription drugs from illegal online pharmacies?How do people stay safe when shopping for medicines online?
  • Earlier you mentioned to verify, if one is buying from a secure website to look to the right of the dot, what kind of protocol does a seller have to go through to own one of these kinds of websites for example a cvs.pharmacy?


Duration: 9:56


Libby Baney is the Founder and Executive Director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C.  In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers. Libby began working on Internet pharmacy issues in 2009 when she helped to launch a loose coalition, which grew into ASOP Global.


A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.


Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.


In addition to her work for ASOP, Libby is a Senior Director at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.



Websites: www.safeonlinerx.com | www.XtheRisk.pharmacy
Follow on Twitter: @safeonlinerx

Growing Problem on Antibiotic Resistance, but There’s Also Reason for Hope

April 6, 2016
00:0000:00


Dr. Ron Najafi, CEO of Emery Pharma Services joins eHealth Radio and the Health News and Pharmaceutical Channels to discuss the alarming concerns about super bugs such as Methicillin Resistance Staphylococcus Aureus (MRSA) and how it’s affecting our global health.


Listen to interview with host Eric Michaels & guest Dr. Ron Najafi discuss the following:

  • How has antibiotic resistance become a growing worldwide public health crisis? Who is to blame for this problem?
  • What are Staphylococcus aureus infections and how are they easily acquired in places like hospitals -- which are meant to keep us healthy?
  • Why are researchers having a hard time replacing the existing arsenal of effective antimicrobial agents?
  • Your company works with companies addressing this problem, what new breakthroughs do you find promising? 
  • What can we be doing as patients to also curb the problem? What safeguards can we take?


Duration: 17:21


After earning a B.S. and M.S. in chemistry at the University of San Francisco, Ron Najafi received his Ph.D. at University of California at Davis. He worked at Sigma-Aldrich, Rhone Poulenc Rorer (now Sanofi), and PerkinElmer-Applied Biosystems before leaving to found CP Lab Safety and NovaBay Pharmaceuticals.  Dr. Najafi is an innate innovator. With more than 50 patents & pending patent applications, including a class of non-antibiotic, antimicrobial compounds named Aganocides®. The leading molecule of this aganocide family of compounds, auriclosene, has a broad spectrum of antimicrobial activity against bacteria, viruses and fungi.


Ron Najafi championed development of NeutroPhase for wound care. In September 2013, working together with John Crew, MD (vascular surgeon) they developed Crew-NovaBay minimally invasive surgical procedure to treat flesh eating bacteria. NeutroPhase has been successfully used in over 40 cases diagnosed as flesh eating infection. NeutroPhase has shown in a number of critical scientific publications to neutralize the key toxins responsible for the flesh eating disease. In 2014, Ron Najafi and her sister, Kathryn (Katy) Najafi, MD (Ophthalmologist & Surgeon) discovered a unique formulation of NeutroPhase to help manage patients suffering from Blepharitis. This unique formulation was initially called i-Lid Cleanser and later changed name to AVENOVA.



Website: www.emerypharmaservices.com


Social Media Links:
Facebook: www.facebook.com/pages/Emeryville-Pharmaceutical-Services
Twitter: @EmeryvillePharm


Are you enjoying the podcast? Please, leave a review.

PerceptiMed, reducing the margin of human error in prescription pill dispensing

March 7, 2016
00:0000:00


Dr. Alan Jacobs M.D., Ph.D., Founder and President of PerceptiMed that was founded in 2011 with a driving purpose — to reduce the margin of human error in prescription pill dispensing in retail pharmacies, long-term care facilities and hospitals joins eHealth Radio and the Health News and Pharmaceutical Channels.


Listen to interview with host Eric Michaels & guest Dr. Alan Jacobs discuss the following:

  • Can you explain the situation involving your father-in-law that led you to start PerceptiMed?
  • What feelings ran through your head when you discovered that a medication error threatened a loved one’s life?
  • As a physician, were you surprised to uncover the prevalence of medication errors?
  • What is the mission of PerceptiMed?
  • Can you give us a background on IdentRx and the impact you see it making on the healthcare industry?
  • How does the Ident-Rx remote allow PerceptiMed to service patients in rural areas?
  • How can MedPass be a valuable asset to hospitals and long-term care facilities? 
  • What is ScripClip and how can ScripClip be a valuable technology for pharmacies?
  • If you could give any advice to people for them to self-identify medications, what would that be?


Duration: 16:40


Alan Jacobs, M.D., Ph.D., the President, CTO & Founder of PerceptiMed is driven to reduce the margin of human error in the administration of prescription drugs. As such, he has focused on creating “first-in-class” technology that eliminates medication errors in retail pharmacies, long-term care facilities and hospitals.


He holds several key patents and is the co-inventor of the IdentRx™ medication verification system. Alan has extensive experience leading international teams in the research and development of therapeutics and medical devices. He began his research and development career at Elan Pharmaceuticals where he designed and managed clinical drug trials, drug development protocols and safety infrastructures for investigating treatments of traumatic brain injury and peri-operative pain management. Dr. Jacobs has also led the clinical development of novel therapeutics at Layton BioScience and Titan Pharmaceuticals before serving as CMO and Vice President of Clinical Research at Stem Cells, Inc., where he led the clinical team developing novel treatments for Batten’s disease.


Alan received a B.S.E.E. from Cornell University and a M.S.E.E from Stanford University. He also holds a Medical Doctorate from the School of Medicine at University of Pennsylvania and a Ph.D. from the David Mahoney Institute of Neuroscience, University Pennsylvania, where he was a Fellow, in the Medical Scientist Training Program of the National Institute of General Medical Sciences. Alan completed an internship in General Surgery and was a resident in Neurological Surgery at the University of California, San Francisco Medical Center.



Website: www.perceptimed.com


Social Media Links:
Facebook: Facebook-PerceptiMed
Linkedin: https://www.linkedin.com/company/perceptimed
Twitter: @perceptimed

SMP Pharmacy Solutions, improving the quality of life for patients through personalized service

February 10, 2016
00:0000:00


Armando Bardisa, President & Founder of SMP Pharmacy Solutions, a specialty pharmacy that is redefining the pharmacy experience through its comprehensive approach to healthcare and its commitment to providing superior customer service and improved patient health joins eHealth Radio and the Health News, Health Care & Pharmaceutical Channels.


Listen to interview with host Eric Michaels & guest Armando Bardisa discuss the following:

  • How did you get into the healthcare industry?
  • Did being a pharmacist by trade have any advantages while you were starting up your business?
  • How does SMP compete with the big box pharmacies like Walgreens and CVS?
  • What does it mean to be a specialty pharmacy?
  • What advice do you have for young entrepreneurs who are looking to get into the healthcare industry today?


Duration: 7:31


Armando Bardisa, Pharm.D, C.Ph., is the President & Founder of SMP Pharmacy Solutions. Dr. Armando Bardisa founded South Miami Pharmacy in 2003 in an effort to improve the quality of life for patients through personalized pharmacy service. A pharmacist by trade and an entrepreneur at heart, Armando has led the company to many notable achievements including the prestigious honor of being named one of the 5000 Fastest Growing Private Companies by Inc. Magazine for seven consecutive years. In addition, SMP was recognized by J.D. Power & Associates as having the “Highest in Customer Satisfaction” rating and was also named a Top 500 Hispanic-Owned Business by Hispanic Business Magazine. Drug Topics Magazine named SMP an “Independent Pharmacy Superstar,” and the company was also recognized by Drug Channels as one of the top ten fastest-growing, private specialty pharmacies. In 2015, South Miami Pharmacy changed its name to SMP Pharmacy Solutions to redefine the company’s position as one of the top independent pharmacies in the country and a trusted healthcare partner to both patients and physicians alike.


Armando is the driving force behind SMP’s four points of service that include compounding, fertility, specialty and retail. He is certified by the American Academy of Anti-Aging Medicine (A4M), a prestigious medical organization that grants physicians and pharmacists the ability to detect, treat and prevent diseases related to the human aging process. SMP Compounding is accredited by the Pharmacy Compounding Accreditation Board (PCAB) and the Professional Compounding Center of America (PCCA), of which Armando is also a member. In addition, SMP has become a national leader in mail order fertility and specialty services, and has a presence in over 31 states.


Committed to playing a role in the future of the pharmaceutical industry, Armando lends his expertise to numerous boards including Nova Southeastern University’s College of Pharmacy Dean’s Advisory Board. He is also on the Board of Directors for the Pharmacy Development Services (PDS), an organization that coaches and trains independent pharmacy owners with the skills they need to be successful. Armando is a member of several industry-centric groups including the American Association of Colleges of Pharmacy, American Pharmacists Association and Specialty Pharmacy Association of America (SPAARx).


Armando compliments his business success with various philanthropic partnerships including the support of Susan G. Komen foundation and St. Jude Children’s Research Hospital, where he participates in the annual triathlon, raising over $50,000 in donations to date. SMP has also provided medicine and medical supplies for various medical missions in Guatemala, Haiti and Honduras. Locally, Armando supports the annual Migrant Toy Drive in Homestead and Blossom’s Developmental Therapy Associates (BDTA), a state-of-the-art facility that provides service and programs for children with special needs, specifically cerebral palsy. This year Armando will participate in the New York City Marathon, running to raise money for Team for Kids, an organization that provides low-cost health and fitness programs to kids who have little access to regular physical activity.


Armando received his Doctor of Pharmacy from Nova Southeastern University, a Bachelor of Science degree from Florida International University and his Consultant Pharmacist License from the University of Florida. In 2010, Armando was awarded an honorary MBA from Florida International University for his success in the pharmaceutical industry. In addition, Armando has been a notable speaker at Pharmacy Development Services’ Showcase of Success, as well as a contributing writer to many local Miami and industry publications including Drug Topics magazine and South Florida Business Journal.



Website: www.smppharmacy.com


Social Media Links:
Facebook: https://www.facebook.com/SouthMiamiPharmacy
Twitter: @smiamipharmacy